Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
Benjamin A. Barsky, Alisa B. Busch, Sadiq Y. Patel, Ateev Mehrotra, Haiden A. Huskamp
Abstract
This cross-sectional study examines the use of telemedicine for buprenorphine inductions among individuals with commercial insurance or Medicare Advantage during the temporary repeal of the Ryan Haight Act requirement of in-person evaluation before prescribing buprenorphine during to the COVID-19 pandemic.
Topics & Concepts
BuprenorphineTelemedicineRepealMedicineReimbursementMedical emergencyBusinessHealth insuranceMedicare AdvantageManaged careActuarial scienceInsurance policyFinanceHealth careOpioid Use Disorder TreatmentGun Ownership and Violence ResearchHIV, Drug Use, Sexual Risk